Clinical Trial Update: Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates Kamuvudine-8 is being evaluated for Geographic Atrophy in Phase 1/2 and the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• Kamuvudine-8 (Kamuvudine-8)

Snippet

Sponsor: Michelle Abou-Jaoude | Conditions: Geographic Atrophy, Age-Related Macular Degeneration | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING